What is our
Raison d'être

HTL Biotechnology’s mission is to unleash the potential of hyaluronic acid and biopolymers for the benefit of those seeking to improve the health and well-being of millions of patients worldwide.

1977

Foundation of Javenech, a biotechnology research lab committed to human health

1992

Foundation of HTL Biotechnology

1992-2006

Pioneer in Hyaluronic Acid production by bacterial fermentation

2007-2016

HTL Biotechnology becomes the world leader in injectable grade Hyaluronic Acid

2017

Investments in large R&D and production projects

2019

Fermentation-based production of new biopolymers of medical interest

2020

Opening of Paris office

Launch of a LabCom for biomaterials

2021

Opening of the new GMP manufacturing facility HTL4

Opening of US and Asia offices

First strategic partnership on functionalization

2023

New GMP chemistry facility to functionalized Biopolymers

A leader for
30 years

The HTL Biotechnology of the future means :

  • the constant creation of new and innovative products thanks to our R&D investments. Our ambition is to continue shaping the future of medicine and the biopolymer market,
  • an ever-increasing number of applications for our biopolymers,
  • a global expansion, from the United States to Asia, while strengthening our teams in France.

Our Values

From product sourcing to partnerships of excellence, we do our very best to guarantee the best service to our customers and partners.

We reliably supply our customers with high-quality, tailor-made products and solutions that perfectly meet their requirements.

For more than 30 years, we have been developing a relationship of trust, hand-to-hand working with each and every one of our customers to provide a personalized approach to their needs.

Today, all over the world, we continue to co-create with our customers and partners innovative, high-performing solutions to meet unmet medical needs, thanks to our biopolymers platform.